Cairo – Mubasher: Kahira Pharmaceuticals reported a 69.3% profit increase during the first quarter of 2016/17, according to a bourse filing.
The company registered EGP 17.77 million profits in Q1, compared with EGP 10.5 million profits for the year-ago period.
Over the fiscal year 2015/16, profits rose 18.4% to EGP 51.3 million.
The stock quote increased by 6.13% to EGP 17.49 by 10:57am Cairo time on Wednesday.
